Novartis

@novartis

An innovative medicines company working to reimagine medicine. See our community guidelines: go.novartis.social/4bqbjuA

+ Follow

Scott Gottlieb, MD 🇺🇸

@scottgottliebmd

Senior Fellow @AEI. Partner @NEA. Contributor @CNBC. 23rd Commissioner of the @US_FDA. Public Boards: @Pfizer @Illumina @TempusAI

+ Follow

Aaron Levine

@aarondlevine

#Bioethics & #SciPolicy @sppgatech Associate Dean @GTLiberalArts @GeorgiaTech #CellManufacturing @CMaT_ERC Views my own, Not my Employer's Also on BlueSky

+ Follow

Jeff Marrazzo

@jeffmarrazzo

Co-founder and former CEO of @Spark_tx, passionate about gene therapy enabling change in our healthcare system | He/him.

+ Follow

FDA Drug Information

@fda_drug_info

Receive the latest drug information from the US FDA. Contact us at 1.855.543.3784 or [email protected]. Privacy Policy - fda.gov/privacy.

+ Follow

National Organization for Rare Disorders (NORD)

@rarediseases

National Organization for Rare Disorders (#NORD) is the voice of the U.S. #RareDisease community for 40+ years strong. Official U.S. sponsor of #RareDiseaseDay.

+ Follow

Life Sciences PA

@lifesciencespa

Ensuring Pennsylvania is the U.S. hub for the life sciences by creating a business and public policy environment which fosters life sciences growth and success.

+ Follow

U.S. FDA

@us_fda

Our posts are FDA Approved! Privacy Policy - go.usa.gov/xFfG8 FDA Authentic Accounts - bit.ly/FDASocial

+ Follow

Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉

@bllphd

Professor @Pennmedicine #CellTherapy #Genetherapy #Inventor #Kymriah #CARTCell @TmunityTx & @CapstanTx CoFounder, Past President @ISCTGlobal, @PNASNexus AE

+ Follow

BioBreak

@biobreakorg

BioBreak brings biotech, pharma, medtech, diagnostic and venture capital executives together to foster a stronger environment for the life sciences.

+ Follow

Castle Creek Biosciences

@castlecreekbio

Dedicated to making life better for people living with genetic diseases.

+ Follow

Synthego

@synthego

CRISPR Solutions for Every Milestone. 🧬

+ Follow

Christina Coughlin

@coughlin582

Oncologist and immunologist, believing that the cure lies within the immune system. CEO, Drug developer, dog lover, Philly sports fan and mom. Tweets are my own

+ Follow

Spark Therapeutics

@spark_tx

Our mission is to unlock the power of gene therapy to accelerate healthcare transformation. Page monitored business hours M-F; sparktx.com/contact-us/

+ Follow

Erin Harris

@erinharris_1

Chief Editor of Cell & Gene

+ Follow

Tmunity Therapeutics

@tmunitytx

Tmunity is now part of Kite, a Gilead Company. Kite’s singular focus is cell therapy to treat and potentially cure cancer. Follow @KitePharma for updates.

+ Follow

Foghorn Therapeutics

@foghorntx

Foghorn is pioneering a new class of medicines that treat serious disease by correcting abnormal gene expression.

+ Follow

Martin Lehr

@mlehrphl

CEO at @Context_Tx, $CNTX. BoD Praesidia BioTherapeutics and @CureDuchenne. Philly biotech champion.

+ Follow

Context Therapeutics

@context_tx

Advancing T Cell Engagers for Solid Tumors

+ Follow